Nuvectis Pharma, Inc.
USD18.33
-10.20 (-35.75%)
CEO
Ron Bentsur
IPO Date
2022-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.83
Prev. Close
$28.53
Day Low
$18.14
Day High
$21.24
52W Low
$5.55
52W High
$29.27
Market Cap
$0.49B
Volume
2.04M
| 35,000 |
| $0.00 |
| 12 Jun 2026 | Sanchez Juan | director | A-Award | Acquired | 35,000 | $0.00 |
| 12 Jun 2026 | Kaplan Matthew L. | director | A-Award | Acquired | 35,000 | $0.00 |
| 9 Jan 2026 | Shemesh Shay | Chief Dev. & Ops. Officer | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | Poradosu Enrique | Chief Science & Business Off | A-Award | Acquired | 150,000 | $0.00 |
| 9 Jan 2026 | Carson Michael J. | Vice President, Finance | A-Award | Acquired | 61,200 | $0.00 |
| 6 Nov 2025 | BENTSUR RON | director, 10 percent owner, officer: Chairman & CEO | P-Purchase | Acquired | 5,000 | $5.72 |
| 6 Nov 2025 | Sanchez Juan | director | P-Purchase | Acquired | 13,000 | $5.79 |